2026 Annual Meeting | C129 - Neurological Consultations in Cancer Patients

Date Tuesday 04/21/26

Time 07:00 AM - 09:00 AM CDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Maya Hrachova, DO

Topic(s) Neuro-oncology

Learning Objectives Participants should become familiar with common neurological complications of systemic cancer, brain, and leptomeningeal metastases and its treatment including surgery, radiation therapy, and chemotherapy; the evidence-based recommendations for managing patients with neurological symptoms in the setting of primary brain tumors; and identify common diagnoses that mimic brain neoplasms.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM CDT	Introduction	Introduction Maya Hrachova, DO
07:05 AM - 07:40 AM CDT	Speaker	Inpatient Neurological Consultations in Cancer Patients Joshua A. Budhu, MD
07:40 AM - 07:45 AM CDT	Q&A	Questions and Answers Joshua A. Budhu, MD
07:45 AM - 08:20 AM CDT	Speaker	Outpatient Neurological Consultations in Cancer Patients David Gritsch, MD, PhD
08:20 AM - 08:25 AM CDT	Q&A	Questions and Answers David Gritsch, MD, PhD
08:25 AM - 08:55 AM CDT	Speaker	Brain and Leptomeningeal Metastases Maya Hrachova, DO
08:55 AM - 09:00 AM CDT	Closing Remarks	Closing Remarks Maya Hrachova, DO

Faculty Disclosures
Maya Hrachova, DO	Dr. Hrachova has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SpringWorks Therapeutics.
Joshua A. Budhu, MD	Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. The institution of Dr. Budhu has received research support from BMSF. The institution of Dr. Budhu has received research support from Commonwealth Fund. The institution of Dr. Budhu has received research support from National Cancer Institute . The institution of Dr. Budhu has received research support from Memorial Sloan Kettering Cancer Center. The institution of Dr. Budhu has received research support from United Hospital Fund. Dr. Budhu has received personal compensation in the range of $500-$4,999 for serving as a Peer Reviewer with Medscape.
David Gritsch, MD, PhD	Dr. Gritsch has nothing to disclose.

��ɫ��

��ɫ��